Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 15, 2023

SELL
$4.65 - $7.37 $8.8 Million - $13.9 Million
-1,891,878 Reduced 31.54%
4,105,779 $19.9 Million
Q3 2022

Nov 14, 2022

SELL
$4.65 - $7.37 $8.8 Million - $13.9 Million
-1,891,878 Reduced 31.54%
4,105,779 $19.9 Million
Q2 2022

May 15, 2023

BUY
$4.21 - $11.15 $25.3 Million - $66.9 Million
5,997,657 New
5,997,657 $27.7 Million
Q2 2022

Aug 15, 2022

SELL
$4.21 - $11.15 $3.65 Million - $9.67 Million
-867,419 Reduced 12.64%
5,997,657 $27.7 Million
Q1 2021

May 14, 2021

BUY
$24.23 - $27.06 $166 Million - $186 Million
6,865,076 New
6,865,076 $172 Million

Others Institutions Holding TIL

About Instil Bio, Inc.


  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.82B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.